Gland Pharma Limited (NSE:GLAND)
India · Delayed Price · Currency is INR 1,690.60
-2.70 (-0.16%)
Jan 7, 2026, 11:50 AM IST
Gland Pharma Market Cap
Gland Pharma has a market cap or net worth of 278.98 billion as of January 6, 2026. Its market cap has decreased by -3.09% in one year.
Market Cap
278.98B
Enterprise Value
249.99B
Revenue
58.01B
Ranking
n/a
PE Ratio
35.29
Stock Price
1,690.60
Market Cap Chart
Since November 20, 2020, Gland Pharma's market cap has decreased from 297.10B to 278.98B, a decrease of -6.10%. That is a compound annual growth rate of -1.22%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 5, 2026 | 279.79B | -1.38% |
| Dec 31, 2025 | 283.71B | -3.22% |
| Dec 31, 2024 | 293.15B | -7.51% |
| Dec 29, 2023 | 316.97B | 22.08% |
| Dec 30, 2022 | 259.64B | -59.11% |
| Dec 31, 2021 | 634.96B | 66.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Nov 20, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.15T |
| Divi's Laboratories | 1.69T |
| Cipla | 1.23T |
| Apollo Hospitals Enterprise | 1.02T |
| Zydus Lifesciences | 922.62B |
| Mankind Pharma | 906.11B |
| Aurobindo Pharma | 701.26B |
| Fortis Healthcare | 691.13B |